DOI:
10.1055/s-00000146
Diabetes aktuell
LinksClose Window
References
Nauck MA, Meier JJ, Schmidt WE.
Incretin-based glucose-lowering medications and the risk of acute pancreatitis and/or pancreatic cancer: reassuring data from cardio-vascular outcome trials.
Diabetes Obes Metab 2017;
19: 1327-1328 doi:10.1111/dom.12981
Access:
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.